WASHINGTON, Dec. 20 -- Rep. Maggie Goodlander, D-New Hampshire, issued the following news release: * * * Congresswoman Goodlander Leads Legislation to Prevent Unauthorized War with Venezuela * Washington, D.C. Yesterday, Congresswoman Maggie Goodlander (NH-02), a Member of the House Armed Services Committee and a former intelligence officer in the United States Navy Reserve, helped introduce the No Unauthorized War with Venezuela Act in the U.S. House of Representatives. The legislation proh more PR

WASHINGTON, Dec. 21 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration issued a notice confirming that several dozen drug products were not removed from the market due to safety or effectiveness concerns. This decision ensures that generic manufacturers can continue to produce or seek approval for versions of these medications. FDA evaluated a list of discontinued applications, including well-known treatments such as the pain medication Demerol, the allergy more PR

WASHINGTON, Dec. 21 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration issued a notice determining that Zantac injection was not withdrawn from sale for reasons of safety or effectiveness, provided manufacturing meets specific impurity limits. This ruling clears a path for pharmaceutical companies to seek approval for generic versions of the drug. Zantac injection, used to treat ulcers and hypersecretory conditions in hospitalized patients, was initially ap more PR

WASHINGTON, Dec. 21 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration considered a change to federal sunscreen standards that would allow a additional active ingredient to be used in sun protection products sold in the U.S. The federal agency announced the availability of a proposed administrative order to amend the existing monograph for over-the-counter sunscreen drug products. If approved, the order will add bemotrizinol at concentrations up to 6 percen more PR